1. Patients with asymptomatic myeloma or D-S stage I can be observed and reviewed every 3 months. 2. Patients with symptomatic MM or asymptomatic but with existing myeloma-related sexual organ failure should be treated early. 3. Age ≤ 65 years, suitable for autologous stem cell transplantation, avoid alkylating agents and nitrosoureas. 4. Those who are suitable for clinical trials should be considered for entry into clinical trials. In addition, myeloma patients should not take medicine in spring and summer: 1. Warm drugs are used to treat cold diseases, and fever, bleeding, sores and other lesions often occur in summer when they are used in large quantities. Even if you have to use them, you can only reduce the dose and shorten the course of treatment. 2, should not be excessive sweating. In summer, the body is prone to sweating, and then take a lot of sweating medicine, is bound to sweat profusely, resulting in water imbalance in the body, and even shock and other critical symptoms. 3, should not be excessive tonic. Tonic medicine is not easily absorbed, only people with perfect digestive function can use it, otherwise there will be abdominal distension, do not think about eating and other phenomena. In the summer, the gastrointestinal function is low, so it is not suitable to use, and avoid excessive tonic.